Brief breakthrough above €30.45: Edenred stock tests its resistance before Q3
The specialist in employee benefits and dedicated payments extends its recovery in a rising Paris market. It ranks among the top performers of its index, just days before its quarterly publication.
A resistance tested during the session, within a rise that has been stretching for three months
The Edenred stock gains 3.01% to €30.43, in an SBF 120 rising 0.36%. It ranks among the strongest gainers in the index. The share broke through its €30.45 resistance during the session, reaching €30.47, before falling slightly below it. This level is therefore within immediate reach. The price remains well above its 50-day moving average (+6.25%) and its 200-day moving average (+33.93%), evidence of an established trend rather than a simple rebound.
The gain reaches 17.67% over three months and 51.39% over one year, while the share had recently declined nearly 7% over the month, a drop that this recovery is already partially offsetting. Upon publication of H1 2026 results (July 23, 2026), the company raised its 2026 EBITDA forecast to €1,250 million. It cited among its risks regulatory changes on meal vouchers in Italy and Brazil. It also highlighted double-digit growth in Mobility.
More constructive analysts and a meeting scheduled for October 21
On the analyst opinion front, UBS raised its target yesterday from €19 to €28.50, while maintaining a neutral rating; this new target remains below the current price of €30.43. On October 14, CIC Market Solutions for its part confirmed its buy rating with a target of €34, approximately 11.7% above the current price. Third quarter 2026 revenue will be published on October 21. This meeting will follow closely on the €30.45 resistance zone, which the share grazed today.
